CELEX: 62012TA0328
Language: en
Date: 2013-10-16 00:00:00
Title: Case T-328/12: Judgment of the General Court of 16 October 2013 — Mundipharma v OHIM — AFT Pharmaceuticals (Maxigesic) (Community trade mark — Opposition proceedings — Application for Community word mark Maxigesic — Earlier Community word mark OXYGESIC — Article 8(1)(b) of Regulation (EC) No 207/2009)

30.11.2013   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 352/14
            
         Judgment of the General Court of 16 October 2013 — Mundipharma v OHIM — AFT Pharmaceuticals (Maxigesic)
   (Case T-328/12) (1)
   
   (Community trade mark - Opposition proceedings - Application for Community word mark Maxigesic - Earlier Community word mark OXYGESIC - Article 8(1)(b) of Regulation (EC) No 207/2009)
   2013/C 352/26
   Language of the case: German
   
      Parties
   
   
      Applicant: Mundipharma GmbH (Limburg an der Lahn, Germany) (represented by: F. Nielsen, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: D. Walicka, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of OHIM, intervener before the General Court: AFT Pharmaceuticals Ltd (Takapuna, New Zealand) (represented by: M. Nentwig, L. Kouker and G.M. Becker, lawyers)
   
      Re:
   
   Action brought against the decision of the Fourth Board of Appeal of OHIM of 23 May 2012 (Case R 1788/2010-4), concerning opposition proceedings between Mundipharma GmbH and AFT Pharmaceuticals Ltd
   
      Operative part of the judgment
   
   The Court:
   
               1.
            
            
               Dismisses the action;
            
         
               2.
            
            
               Orders Mundipharma GmbH to pay the costs.
            
         
      (1)  OJ C 287, 22.9.2012.